Concert Wealth Management Inc. lowered its position in Danaher Corp. (NYSE:DHR) by 2.1% during the second quarter, Holdings Channel reports. The institutional investor owned 5,923 shares of the company’s stock after selling 125 shares during the period. Concert Wealth Management Inc.’s holdings in Danaher Corp. were worth $596,000 at the end of the most recent quarter.
A number of other large investors also recently modified their holdings of DHR. Bristlecone Advisors LLC raised its stake in shares of Danaher Corp. by 10.1% in the first quarter. Bristlecone Advisors LLC now owns 4,376 shares of the company’s stock worth $415,000 after buying an additional 400 shares in the last quarter. Sentry Investment Management LLC raised its stake in shares of Danaher Corp. by 1.9% in the first quarter. Sentry Investment Management LLC now owns 46,181 shares of the company’s stock worth $4,381,000 after buying an additional 870 shares in the last quarter. Massmutual Trust Co. FSB ADV raised its stake in shares of Danaher Corp. by 6.0% in the first quarter. Massmutual Trust Co. FSB ADV now owns 41,869 shares of the company’s stock worth $3,972,000 after buying an additional 2,366 shares in the last quarter. Findlay Park Partners LLP raised its stake in shares of Danaher Corp. by 1.0% in the first quarter. Findlay Park Partners LLP now owns 3,378,763 shares of the company’s stock worth $320,509,000 after buying an additional 34,303 shares in the last quarter. Finally, Nikko Asset Management Americas Inc. bought a new stake in shares of Danaher Corp. during the first quarter worth approximately $304,000. 75.74% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Corp. (NYSE:DHR) traded up 1.10% during mid-day trading on Wednesday, hitting $77.18. 1,620,808 shares of the stock were exchanged. The company has a market capitalization of $53.30 billion, a PE ratio of 15.35 and a beta of 1.13. Danaher Corp. has a 1-year low of $61.60 and a 1-year high of $82.64. The stock has a 50 day moving average price of $78.52 and a 200 day moving average price of $76.77.
Danaher Corp. (NYSE:DHR) last released its quarterly earnings results on Monday, July 25th. The company reported $1.25 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.22 by $0.03. The company had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.76 billion. Danaher Corp. had a return on equity of 13.40% and a net margin of 15.88%. The business’s quarterly revenue was up 16.6% compared to the same quarter last year. During the same period in the previous year, the business posted $1.08 earnings per share. On average, equities analysts anticipate that Danaher Corp. will post $3.56 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, September 30th will be issued a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a dividend yield of 0.65%. The ex-dividend date is Wednesday, September 28th. Danaher Corp.’s dividend payout ratio (DPR) is currently 9.94%.
DHR has been the topic of a number of research analyst reports. Sanford C. Bernstein raised shares of Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price objective on the stock in a report on Thursday, June 23rd. Barclays PLC reaffirmed an “overweight” rating and issued a $105.00 target price on shares of Danaher Corp. in a research note on Monday, June 27th. Zacks Investment Research lowered shares of Danaher Corp. from a “hold” rating to a “sell” rating in a research note on Wednesday, June 29th. JPMorgan Chase & Co. reaffirmed a “buy” rating and issued a $105.00 target price on shares of Danaher Corp. in a research note on Thursday, June 30th. Finally, Goldman Sachs Group Inc. initiated coverage on shares of Danaher Corp. in a research note on Tuesday, July 5th. They issued a “neutral” rating and a $74.00 target price on the stock. Eight analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $93.10.
In related news, CFO Daniel L. Comas sold 96,446 shares of the company’s stock in a transaction that occurred on Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total value of $7,800,552.48. Following the sale, the chief financial officer now directly owns 215,716 shares in the company, valued at $17,447,110.08. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the company’s stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $81.44, for a total value of $3,737,851.68. Following the completion of the sale, the insider now owns 179,054 shares in the company, valued at $14,582,157.76. The disclosure for this sale can be found here. Insiders own 12.60% of the company’s stock.
Danaher Corp. Company Profile
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.